We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Hongliang Li

Hongliang Li MD, PhD

Dean, Basic Medical School, Wuhan University; Director, Institute of Model Animal, Wuhan University; Director, Medical Research Institute, Zhongnan Hosptial, Wuhan, China

Recent Contributions to PracticeUpdate:

  1. Risks and Impact of ACE Inhibitors or ARBs in COVID-19